Reviva Pharmaceuticals Holdings Inc (RVPHW) — Financial Flexibility Index
Reviva Pharmaceuticals Holdings Inc (RVPHW) has a Financial Flexibility Index of -0.57x as of September 2025. Free cash flow of $-5.59 Million (operating CF $-5.59 Million minus capex $4.00) represents -1% of total liabilities ($9.78 Million). Check RVPHW capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Reviva Pharmaceuticals Holdings Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Reviva Pharmaceuticals Holdings Inc across 7 annual periods. For the full cash flow conversion analysis, see Reviva Pharmaceuticals Holdings Inc cash flow conversion.
Annual Financial Flexibility Index for Reviva Pharmaceuticals Holdings Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Reviva Pharmaceuticals Holdings Inc. Explore Reviva Pharmaceuticals Holdings Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.28x | $-33.54 Million | $-33.54 Million | $14.69 Million | ▼ -45.0% |
| 2023 | -1.58x | $-28.32 Million | $-28.32 Million | $17.98 Million | ▲ +12.5% |
| 2022 | -1.80x | $-18.96 Million | $-18.96 Million | $10.53 Million | ▲ +54.1% |
| 2021 | -3.93x | $-10.67 Million | $-10.67 Million | $2.72 Million | ▼ -218.2% |
| 2020 | -1.23x | $-4.07 Million | $-4.07 Million | $3.30 Million | ▼ -3748.1% |
| 2019 | -0.03x | $-218.44K | $-218.44K | $6.81 Million | ▲ +81.8% |
| 2018 | -0.18x | $-1.07 Million | $-1.07 Million | $6.09 Million | — |